Suppr超能文献

血清D-二聚体水平用于排除急性主动脉夹层的回顾性分析

A Retrospective Analysis of Serum D-Dimer Levels for the Exclusion of Acute Aortic Dissection.

作者信息

Zitek Tony, Hashemi Mani, Zagroba Sara, Slane Valori H

机构信息

Department of Emergency Medicine, Mount Sinai Medical Center, Miami Beach, FL, USA.

Department of Emergency Medicine, Kendall Regional Medical Center, Miami, FL, USA.

出版信息

Open Access Emerg Med. 2022 Jul 28;14:367-373. doi: 10.2147/OAEM.S373335. eCollection 2022.

Abstract

PURPOSE

Acute aortic dissection (AAD) is a highly fatal disorder if not promptly diagnosed. Some international studies have suggested that serum d-dimer levels may be used to exclude AAD, but data are limited. We sought to confirm that d-dimer levels are elevated in American patients with AAD. Additionally, we sought to estimate the test characteristics of the d-dimer for AAD.

PATIENTS AND METHODS

We performed a retrospective analysis of patients in the Hospital Corporation of America database who arrived at the hospital between 2015 and 2019. We queried the database to find patients who had a diagnosis of AAD or (nonspecific) chest pain, and who also had a d-dimer performed within 24 hours of arrival at the hospital. The median d-dimer was compared in those diagnosed with AAD versus chest pain. We estimated the test characteristics of d-dimer for AAD at the standard cutoff value of 500 ng/mL.

RESULTS

In total, 48,902 patients met the criteria for analysis, including 572 with AAD and 48,330 with chest pain. The median d-dimers were 2455 ng/mL and 385 ng/mL for the AAD and chest pain groups, respectively (p < 0.0001). Using a cutoff of 500 ng/mL, the sensitivity of the d-dimer was 91.1% and the specificity was 71.4%.

CONCLUSION

Serum d-dimer values are higher in patients with AAD than in those with nonspecific chest pain. At the standard cutoff of 500 ng/mL, the serum d-dimer has a high sensitivity for AAD, but not high enough that d-dimer levels alone can be used in isolation to exclude AAD.

摘要

目的

急性主动脉夹层(AAD)若不及时诊断,是一种致死率很高的疾病。一些国际研究表明,血清D-二聚体水平可用于排除AAD,但相关数据有限。我们试图证实美国AAD患者的D-二聚体水平升高。此外,我们还试图评估D-二聚体检测AAD的特征。

患者与方法

我们对美国医院集团数据库中2015年至2019年入院的患者进行了回顾性分析。我们查询数据库以找出诊断为AAD或(非特异性)胸痛且在入院后24小时内进行了D-二聚体检测的患者。比较了诊断为AAD与胸痛患者的D-二聚体中位数。我们在500 ng/mL的标准临界值下评估了D-二聚体检测AAD的特征。

结果

共有48,902例患者符合分析标准,其中572例为AAD患者,48,330例为胸痛患者。AAD组和胸痛组的D-二聚体中位数分别为2455 ng/mL和385 ng/mL(p<0.0001)。以500 ng/mL为临界值,D-二聚体的敏感性为91.1%,特异性为71.4%。

结论

AAD患者的血清D-二聚体值高于非特异性胸痛患者。在500 ng/mL的标准临界值下,血清D-二聚体对AAD具有较高的敏感性,但敏感性还不足以仅依据D-二聚体水平来排除AAD。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验